Clarus Therapeutics (NASDAQ:CRXT), Greenidge Generation (NASDAQ:GREE) Stock In Focus After Analysts Commentary
Clarus Therapeutics (NASDAQ:CRXT): Finally, A Safe Oral Testosterone Replacement Therapy – Initiating Coverage with a Buy Rating and $13 Price Target – Maxim Group
Maxim’s Naz Rahman states, “We forecast Jatenzo’s commercialization from 2021-2030 based on expected patent expiry. We model market penetration for treating the hypogonadism market and forecast increasing market share per year with estimates made for gross-to-net adjustments, annual price increases, and net pricing. We apply a 25% discount rate to the free cash flow, discounted EPS, and sum-of-the-parts models, which are equally weighted to derive a 12-month price target of $13.”
Greenidge Generation (NASDAQ:GREE): Going Vertical: Bitcoin Miner GREE Offers Advantages at a Discount—Initiating Coverage at Buy, $78 PT – B. Riley Securities
B. Riley Securities’ Lucas Pipes states, “Greenidge is a leading digital asset miner that is scaling rapidly at its vertically integrated New York operations and has a further medium- and longterm growth runway via its Spartanburg, South Carolina, facility. GREE has been a digital asset miner since 2019 and had approximately 11,700 Bitcoin miners deployed as of June 30, with an estimated company hash rate of 0.83 EH/s. Importantly, we estimate that Greenidge will deploy an additional 5,386 miners over the course of 2021 and another 18,300 miners in 2022.
We believe that Greenidge can fund this growth with cash on hand, free cash flow, and borrowings. The low probability of equity dilution is a key differentiation from the peer group. We expect that Greenidge will be able to reach a hash rate of 3.1 EH/s by the end of 2022 and 6.8 EH/s by the end of 2023, as Greenidge is moving toward its goal of 500 MW of mining capacity by 2025. Greenidge is trading at just 8.0x 2022 and 4.1x 2023 estimated EBITDA, respectively, an attractive value, we believe, for a high-quality, vertically integrated, and well-capitalized miner.”